Keywords: تومور استرومای گوارشی; CT; Computed tomography; GIST; Gastrointestinal stromal tumor; Case report; Gastrointestinal stromal tumour; Haemoperitoneum; Imatinib; Small intestine; Tumour rupture;
مقالات ISI تومور استرومای گوارشی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تومور استرومای گوارشی; Obscure gastrointestinal bleeding; Gastrointestinal stromal tumour; Jejunum; Small intestine; Sangrado de tubo digestivo de origen oscuro; Tumor de estroma gastrointestinal; Yeyuno; Intestino delgado;
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Second tumours; Metachronous second primary; Synchronous neoplasm; Tumor del estroma gastrointestinal; Segundos tumores; Segundo primario metacrónico; Neoplasia sincrónica;
Keywords: تومور استرومای گوارشی; Tumor del estroma gastrointestinal; Segundos tumores; Segundo primario metacrónico; Neoplasia sincrónica; Gastrointestinal stromal tumour; Second tumours; Metachronous second primary; Synchronous Neoplasm;
Keywords: تومور استرومای گوارشی; Achalasia; adenocarcinoma; atresia; Barrett's oesophagus; gastrointestinal stromal tumour; Helicobacter pylori gastritis; marginal zone lymphoma; oesophagus; squamous cell carcinoma; stomach;
Keywords: تومور استرومای گوارشی; Follow-up; Gastrointestinal stromal tumour; GIST; Surgery; Treatment guidelines; Risk stratification; Computerised tomography; Radiation exposure;
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Synchronous neoplasms; Multiple neoplasms; Review; Classification; Tumor del estroma gastrointestinal; Neoplasia sincrónica; Neoplasias múltiples; Revisión; Clasificación;
Keywords: تومور استرومای گوارشی; Biopsy; Gastrointestinal stromal tumour; Prognosis; Proliferation;
Keywords: تومور استرومای گوارشی; gastrointestinal stromal tumour; metastasis; revision total hip arthroplasty;
Keywords: تومور استرومای گوارشی; Achalasia; adenocarcinoma; artresia; Barrett's oesophagus; gastrointestinal stromal tumour; Helicobacter pylori gastritis; marginal zone lymphoma; oesophagus; squamous cell carcinoma; stomach
Keywords: تومور استرومای گوارشی; Gastric carcinoma; gastrointestinal stromal tumour; GIST; hepatocellular carcinoma; anal melanoma; colorectal carcinoma; rectal carcinoma; pregnancy;
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Surgery; Imatinib;
Keywords: تومور استرومای گوارشی; Submucosal tumour; Gastrointestinal stromal tumour; GIST; Incidental GIST; Guidelines; NCCN; Laparoscopic surgery; Mitosis; Risk stratification;
Surgical management of metastatic gastrointestinal stromal tumour
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Metastasis; Surgery; Tyrosine kinase inhibitor;
Original ResearchClinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; PDGFRA exon 18; D842V; Imatinib;
Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour – Does it increase the risk for tumour cell seeding and recurrence?
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Needle biopsy; Imatinib; Adjuvant; Risk of recurrence
Hemorragia de tubo digestivo secundaria a tumor del estroma gastrointestinal localizado en yeyuno. Reporte de un caso
Keywords: تومور استرومای گوارشی; Tumor del estroma gastrointestinal; Tumor del estroma gastrointestinal yeyuno; Hemorragia gastrointestinal; Gastrointestinal stromal tumour; Jejunum gastrointestinal stromal tumour; Gastrointestinal bleeding;
Prognosis and management of adult wild type gastrointestinal stromal tumours (GISTs): A pooled analysis and review of literature
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Management; Prognosis; Wild-type;
Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT)
Keywords: تومور استرومای گوارشی; Imatinib; Rechallenge; Quality of life; Gastrointestinal stromal tumour;
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting
Keywords: تومور استرومای گوارشی; Imatinib; Gastrointestinal stromal tumour; Therapeutic drug monitoring;
Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction
Keywords: تومور استرومای گوارشی; Laparoscopic; Stomach; Gastrointestinal stromal tumour; Neoadjuvant treatment; Imatinib; Downstaging
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Risk stratification; Computerised tomography; Magnetic resonance imaging; Positron emission tomography; Imatinib; Adjuvant treatment; Treatment guidelines;
Gastrointestinal stromal tumours: Correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker
Keywords: تومور استرومای گوارشی; 3D; three-dimensional; ADC; apparent diffusion coefficient; CT; computed tomography; DW; diffusion-weighted; GIST; gastrointestinal stromal tumour; MR; magnetic resonance; NIH; National Institutes of Health; PACS; picture archiving and communication syste
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Nomogram; Prognosis; Imatinib;
Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Regorafenib; Tumour response criteria; RECIST; Choi
Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: Prognostic implications
Keywords: تومور استرومای گوارشی; GIST; Gastrointestinal stromal tumour; Coexistence; Malignancy; Imatinib mesylate
Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Tyrosine kinase inhibitors; Imatinib; Sunitinib; Side effects; Symptoms
Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; c-kit exon 11; Deletion mutation; Imatinib; Dog;
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; KIT; p.K642E; Imatinib; Germline mutation; Prognosis;
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Keywords: تومور استرومای گوارشی; Rare cancers; Soft tissue sarcomas; Bone sarcomas; Gastrointestinal stromal tumour; Incidence; Survival; Prevalence;
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Sorafenib; Nilotinib; Sunitinib; Imatinib; Tyrosine kinase inhibitor; Relapse; Salvage; Progression
Risk assessment and pathological reporting of gastrointestinal stromal tumour
Keywords: تومور استرومای گوارشی; adjuvant treatment; gastrointestinal stromal tumour; GIST; KIT mutation; risk assessment; rupture; serosal penetration; tyrosine kinase inhibitor;
Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours
Keywords: تومور استرومای گوارشی; GIST; Gastrointestinal stromal tumour; IGF2; IGF1R;
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
Keywords: تومور استرومای گوارشی; Positron emission tomography; Fluorodeoxyglucose; Imatinib mesylate; c-kit; Receptor protein-tyrosine kinase; Gastrointestinal stromal tumour; Soft-tissue sarcoma
Management of gastrointestinal stromal tumours of limited size: Proposals from a French panel of physicians
Keywords: تومور استرومای گوارشی; Endoscopic ultrasonography; Endoscopy; Gastrointestinal stromal tumour; GIST; Ultrasound;
Cytological, Immunohistochemical and Mutational Analysis of a Gastric Gastrointestinal Stromal Tumour in a Cat
Keywords: تومور استرومای گوارشی; cat; CD117; gastrointestinal stromal tumour; KIT
Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - A population-based study
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Mutations; Imatinib; Sunitinib; c-kit; PDGFRα;
Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes
Keywords: تومور استرومای گوارشی; GIST; Gastrointestinal stromal tumour; Prognosis; Surgery; Tumour rupture; Risk criteria
Pre-operative imatinib treatment of gastrointestinal stromal tumour (GIST) abolishes immunostaining for c-kit – A pitfall for the unwary pathologist
Keywords: تومور استرومای گوارشی; gastrointestinal stromal tumour; imatinib; leiomyoma; protein-tyrosine kinase KIT
Anal spindle cell lesion
Keywords: تومور استرومای گوارشی; anal melanoma; anal spindle cell lesions; c-kit; gastrointestinal stromal tumour; gene-targeted therapy; Glivec/imatinib; KIT mutational analysis
Metastatic gastrointestinal stromal tumours of the stomach: A report on two cases and literature review
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Lymph node metastases; Imatinib; c-Kit
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Nilotinib; Sunitinib; Imatinib; Tyrosine kinase inhibitor; Compassionate use
Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)
Keywords: تومور استرومای گوارشی; Diagnosis; Management; Gastrointestinal stromal tumour; Hepatic metastasis
Gastrointestinal stromal tumour in the elderly
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Elderly; Imatinib;
Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom)
Keywords: تومور استرومای گوارشی; GIST; Gastrointestinal stromal tumour; CD117; Resection margins; Recurrence;
The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour
Keywords: تومور استرومای گوارشی; Sunitinib; Gastrointestinal stromal tumour; Access; Cancer; Reimbursement; Cost-effectiveness analysis; Crossover trial; Decision-making
Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; Immunohistochemistry; Mutational analysis; Soft tissue tumours; Clinical trials; Pathology; Prognoses
Sunitinib in the management of gastrointestinal stromal tumours (GISTs)
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; GIST; Sunitinib; Phase III trial; Protein kinase inhibitorsFDA, Food and Drug Administration; FLT3, fms-like tyrosine kinase-3 receptor; GIST, gastrointestinal stromal tumour; MTTP, median time to progression; PDGFR, plate
Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: Lessons from the phase 3 trials
Keywords: تومور استرومای گوارشی; Gastrointestinal stromal tumour; KIT; Platelet-derived growth factor receptor alpha; Genotype; Mutational analysis; Imatinib; Dose optimisation
Gastric tumours
Keywords: تومور استرومای گوارشی; cardia; gastric adenocarcinoma; gastrointestinal stromal tumour; Helicobacter pylori; lymphoma; maltoma